Continuous glucose monitoring (CGM) systems have revolutionized diabetes management by providing real-time data on glucose levels, and new data supports the safety and accuracy of Senseonics 365-day CGM. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the study's key findings.

Aortic aneurysms pose significant health risks. The FDA's approval of Cook Medical's endovascular graft trial represents a positive development in treating this condition. Hear how Cook Medical wants to make the gold-standard treatment of aortic aneurysms easier. 

Diabetes management is not limited to insulin users alone, and Dexcom's endeavor to develop a glucose sensor for non-insulin users reflects a commitment to inclusivity. Whooley explains what the technology will cover and how Medicare will cover the innovation.

Medtronic's appointment of Greg Lewis as director adds another seasoned professional with extensive financial experience to the company's leadership team. The Fast Five hosts detail his prior experience and CEO Geoff Martha's thoughts.

Mergers and acquisitions are common in the medical device industry as companies seek to enhance their product portfolios. Whooley and Kirsh outline Restor3d's plan to acquire Conformis, including when the transaction is expected to close and what executives at both companies are thinking.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

Ver todos los episodios